Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer.

Kenjiro OkadaKenichiro UemuraNaru KondoTatsuaki SumiyoshiShingo SeoHiroyuki OtsukaMasahiro SerikawaYasutaka IshiiTomofumi TsuboiYoshiaki MurakamiShinya Takahashi

Published in: Langenbeck's archives of surgery (2021)

Patients with BR/LAPC who underwent surgery after NAT had significantly lower N2 status and better prognosis than patients who underwent UFS. Elevated CA19-9 levels after NAT indicated a higher nodal status.

Keyphrases

lymph node
end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
neoadjuvant chemotherapy
peritoneal dialysis
rectal cancer
locally advanced
stem cells
squamous cell carcinoma
coronary artery disease
mesenchymal stem cells
acute coronary syndrome
protein kinase
atrial fibrillation